Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
However, no significant correlations were observed between the densitometry results and serum levels of calcium, phosphorus, alkaline phosphatase, or 25-hydroxyvitamin D.
Source: BMD and TBS. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The motor ability of all the patients was assessed by a pediatric orthopedic surgeon (U.G.) according to two scores: the Gross Motor Function Classification System (GMFCS) and the Functional Mobility Scale (FMS).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Bone health and bisphosphonate treatment in females with Rett syndrome in a national center
Study design awaiting verification · Pediatric Research · 2025
Original publication title
Bone health and bisphosphonate treatment in females with Rett syndrome in a national center
© The Author(s) 2025
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Impaired bone health is a common morbidity in Rett syndrome (RTT). We aimed to assess lumbar bone mineral density (BMD) and trabecular bone score (TBS) in females with RTT, and to evaluate the effectiveness of bisphosphonate treatment.
Source: BackgroundAbstract: What methods does the paper describe?
This retrospective study included 40 females with RTT, aged 5 to 22 years, who underwent dual-energy X-ray absorptiometry (DXA) scans during 2019 to 2024 at a national center for RTT. Data collected included medical treatment, anthropometric measurements, and functional scores.
Source: MethodsAbstract: Impact
In a retrospective study of 40 females with Rett syndrome (RTT), low bone mineral density (BMD) correlated with lower anthropometric measurements, impaired mobility, and valproic acid use.
The association between BMD and trabecular bone score (TBS) in the context of RTT is a novel finding.
Our preliminary data support the effectiveness and safety of zoledronate for treating osteoporosis in patients with RTT.
Our findings are important in light of the increasing life expectancy of individuals with RTT, and the consequent need to prioritize bone health in this population.
Source: Impact
Abstract: Results
The median age at the first DXA scan was 10.8 years. The mean L1: 4 BMD Z-score was −2.1 ± 1.4, and the mean TBS Z-score was −0.4 ± 1.3. The L1: 4 BMD Z-score correlated with height (r = 0.407, p = 0.009), weight (r = 0.551, p < 0.001), BMI (r = 0.644, p < 0.001), and TBS Z-scores (r = 0.594, p = 0.009). Poor L1: 4 BMD Z-scores were associated with poor mobility scores (p = 0.05) and valproate treatment (p = 0.016).
Nine patients (23%) received zoledronate, for a mean 2 years. The mean age at zoledronate initiation was 9.7 ± 2.3 years. Four completed two DXA scans (pre: and post-treatment); the mean BMD Z-score improved from −2.2 ± 0.9 to −1.4 ± 0.9 after treatment.
Source: ResultsAbstract: Conclusions
Females with RTT have reduced lumbar BMD, which was associated with anthropometric factors, TBS, mobility, and valproate use. Zoledronate may be effective for some patients.
Source: ConclusionsAuthors’ abstract
Background
Impaired bone health is a common morbidity in Rett syndrome (RTT). We aimed to assess lumbar bone mineral density (BMD) and trabecular bone score (TBS) in females with RTT, and to evaluate the effectiveness of bisphosphonate treatment.
Methods
This retrospective study included 40 females with RTT, aged 5 to 22 years, who underwent dual-energy X-ray absorptiometry (DXA) scans during 2019 to 2024 at a national center for RTT. Data collected included medical treatment, anthropometric measurements, and functional scores.
Results
The median age at the first DXA scan was 10.8 years. The mean L1: 4 BMD Z-score was −2.1 ± 1.4, and the mean TBS Z-score was −0.4 ± 1.3. The L1: 4 BMD Z-score correlated with height (r = 0.407, p = 0.009), weight (r = 0.551, p < 0.001), BMI (r = 0.644, p < 0.001), and TBS Z-scores (r = 0.594, p = 0.009). Poor L1: 4 BMD Z-scores were associated with poor mobility scores (p = 0.05) and valproate treatment (p = 0.016).
Nine patients (23%) received zoledronate, for a mean 2 years. The mean age at zoledronate initiation was 9.7 ± 2.3 years. Four completed two DXA scans (pre: and post-treatment); the mean BMD Z-score improved from −2.2 ± 0.9 to −1.4 ± 0.9 after treatment.
Conclusions
Females with RTT have reduced lumbar BMD, which was associated with anthropometric factors, TBS, mobility, and valproate use. Zoledronate may be effective for some patients.
Impact
In a retrospective study of 40 females with Rett syndrome (RTT), low bone mineral density (BMD) correlated with lower anthropometric measurements, impaired mobility, and valproic acid use.
The association between BMD and trabecular bone score (TBS) in the context of RTT is a novel finding.
Our preliminary data support the effectiveness and safety of zoledronate for treating osteoporosis in patients with RTT.
Our findings are important in light of the increasing life expectancy of individuals with RTT, and the consequent need to prioritize bone health in this population.
Publication and source details
Original title: Bone health and bisphosphonate treatment in females with Rett syndrome in a national center
Yael Levy-Shraga; Simon Goldmann; Noah Gruber; Liana Tripto-Shkolnik; Dalit Modan-Moses; Uri Givon; Bruria Ben-Zeev
Pediatric Research · 2025
© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T06:11:36.326789+00:00
DOI: 10.1038/s41390-025-04001-4 · PMC12602358